The Texas children's medication algorithm project: Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder

Steven R. Pliszka, M. Lynn Crismon, Carroll W. Hughes, C. Keith Corners, Graham J. Emslie, Peter S. Jensen, James T. McCracken, James M. Swanson, Molly Lopez

Research output: Contribution to journalArticle

306 Citations (Scopus)

Abstract

Objective: In 1998, the Texas Department of Mental Health and Mental Retardation developed algorithms for medication treatment of attention-deficit/hyperactivity disorder (ADHD). Advances in the psychopharmacology of ADHD and results of a feasibility study of algorithm use in community mental health centers caused the algorithm to be modified and updated. Method: We convened a consensus conference of academic clinicians and researchers, practicing clinicians, administrators, consumers, and families to revise the algorithms for the pharmacotherapy of ADHD itself as well as ADHD with specific comorbid disorders. New research was reviewed by national experts, and rationales were provided for proposed changes and additions to the algorithms. The changes to the algorithms were discussed and approved both by the national experts and experienced clinicians from the Texas public mental health system. Results: The panel developed consensually agreed-upon algorithms for ADHD with and without comorbid disorders. The major changes included elimination of pemoline as a treatment option, adding atomoxetine to the algorithm, and refining guidelines for treating ADHD with comorbid depression, aggressive behaviors, and tic disorders. Conclusions: Medication algorithms for ADHD can be modified to keep abreast of developments in the field. Although these evidence- and consensus-based treatment recommendations may be a useful approach to guide the treatment of ADHD in children, additional research is needed to determine how these algorithms can be used to maximally benefit child outcomes.

Original languageEnglish (US)
Pages (from-to)642-657
Number of pages16
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume45
Issue number6
DOIs
StatePublished - Jun 2006

Fingerprint

Attention Deficit Disorder with Hyperactivity
Drug Therapy
Consensus
Mental Health
Pemoline
Tic Disorders
Community Mental Health Centers
Psychopharmacology
Feasibility Studies
Therapeutics
Administrative Personnel
Research
Mental Disorders
Intellectual Disability
Public Health
Research Personnel
Guidelines
Depression

Keywords

  • Algorithm
  • Attention-deficit/hyperactivity disorder
  • Practice parameters
  • Psychopharmacology

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Developmental and Educational Psychology

Cite this

The Texas children's medication algorithm project : Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. / Pliszka, Steven R.; Crismon, M. Lynn; Hughes, Carroll W.; Corners, C. Keith; Emslie, Graham J.; Jensen, Peter S.; McCracken, James T.; Swanson, James M.; Lopez, Molly.

In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 45, No. 6, 06.2006, p. 642-657.

Research output: Contribution to journalArticle

Pliszka, Steven R. ; Crismon, M. Lynn ; Hughes, Carroll W. ; Corners, C. Keith ; Emslie, Graham J. ; Jensen, Peter S. ; McCracken, James T. ; Swanson, James M. ; Lopez, Molly. / The Texas children's medication algorithm project : Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. In: Journal of the American Academy of Child and Adolescent Psychiatry. 2006 ; Vol. 45, No. 6. pp. 642-657.
@article{8f07aff2902c4d29a50522eb32c33822,
title = "The Texas children's medication algorithm project: Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder",
abstract = "Objective: In 1998, the Texas Department of Mental Health and Mental Retardation developed algorithms for medication treatment of attention-deficit/hyperactivity disorder (ADHD). Advances in the psychopharmacology of ADHD and results of a feasibility study of algorithm use in community mental health centers caused the algorithm to be modified and updated. Method: We convened a consensus conference of academic clinicians and researchers, practicing clinicians, administrators, consumers, and families to revise the algorithms for the pharmacotherapy of ADHD itself as well as ADHD with specific comorbid disorders. New research was reviewed by national experts, and rationales were provided for proposed changes and additions to the algorithms. The changes to the algorithms were discussed and approved both by the national experts and experienced clinicians from the Texas public mental health system. Results: The panel developed consensually agreed-upon algorithms for ADHD with and without comorbid disorders. The major changes included elimination of pemoline as a treatment option, adding atomoxetine to the algorithm, and refining guidelines for treating ADHD with comorbid depression, aggressive behaviors, and tic disorders. Conclusions: Medication algorithms for ADHD can be modified to keep abreast of developments in the field. Although these evidence- and consensus-based treatment recommendations may be a useful approach to guide the treatment of ADHD in children, additional research is needed to determine how these algorithms can be used to maximally benefit child outcomes.",
keywords = "Algorithm, Attention-deficit/hyperactivity disorder, Practice parameters, Psychopharmacology",
author = "Pliszka, {Steven R.} and Crismon, {M. Lynn} and Hughes, {Carroll W.} and Corners, {C. Keith} and Emslie, {Graham J.} and Jensen, {Peter S.} and McCracken, {James T.} and Swanson, {James M.} and Molly Lopez",
year = "2006",
month = "6",
doi = "10.1097/01.chi.0000215326.51175.eb",
language = "English (US)",
volume = "45",
pages = "642--657",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - The Texas children's medication algorithm project

T2 - Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder

AU - Pliszka, Steven R.

AU - Crismon, M. Lynn

AU - Hughes, Carroll W.

AU - Corners, C. Keith

AU - Emslie, Graham J.

AU - Jensen, Peter S.

AU - McCracken, James T.

AU - Swanson, James M.

AU - Lopez, Molly

PY - 2006/6

Y1 - 2006/6

N2 - Objective: In 1998, the Texas Department of Mental Health and Mental Retardation developed algorithms for medication treatment of attention-deficit/hyperactivity disorder (ADHD). Advances in the psychopharmacology of ADHD and results of a feasibility study of algorithm use in community mental health centers caused the algorithm to be modified and updated. Method: We convened a consensus conference of academic clinicians and researchers, practicing clinicians, administrators, consumers, and families to revise the algorithms for the pharmacotherapy of ADHD itself as well as ADHD with specific comorbid disorders. New research was reviewed by national experts, and rationales were provided for proposed changes and additions to the algorithms. The changes to the algorithms were discussed and approved both by the national experts and experienced clinicians from the Texas public mental health system. Results: The panel developed consensually agreed-upon algorithms for ADHD with and without comorbid disorders. The major changes included elimination of pemoline as a treatment option, adding atomoxetine to the algorithm, and refining guidelines for treating ADHD with comorbid depression, aggressive behaviors, and tic disorders. Conclusions: Medication algorithms for ADHD can be modified to keep abreast of developments in the field. Although these evidence- and consensus-based treatment recommendations may be a useful approach to guide the treatment of ADHD in children, additional research is needed to determine how these algorithms can be used to maximally benefit child outcomes.

AB - Objective: In 1998, the Texas Department of Mental Health and Mental Retardation developed algorithms for medication treatment of attention-deficit/hyperactivity disorder (ADHD). Advances in the psychopharmacology of ADHD and results of a feasibility study of algorithm use in community mental health centers caused the algorithm to be modified and updated. Method: We convened a consensus conference of academic clinicians and researchers, practicing clinicians, administrators, consumers, and families to revise the algorithms for the pharmacotherapy of ADHD itself as well as ADHD with specific comorbid disorders. New research was reviewed by national experts, and rationales were provided for proposed changes and additions to the algorithms. The changes to the algorithms were discussed and approved both by the national experts and experienced clinicians from the Texas public mental health system. Results: The panel developed consensually agreed-upon algorithms for ADHD with and without comorbid disorders. The major changes included elimination of pemoline as a treatment option, adding atomoxetine to the algorithm, and refining guidelines for treating ADHD with comorbid depression, aggressive behaviors, and tic disorders. Conclusions: Medication algorithms for ADHD can be modified to keep abreast of developments in the field. Although these evidence- and consensus-based treatment recommendations may be a useful approach to guide the treatment of ADHD in children, additional research is needed to determine how these algorithms can be used to maximally benefit child outcomes.

KW - Algorithm

KW - Attention-deficit/hyperactivity disorder

KW - Practice parameters

KW - Psychopharmacology

UR - http://www.scopus.com/inward/record.url?scp=33744827954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744827954&partnerID=8YFLogxK

U2 - 10.1097/01.chi.0000215326.51175.eb

DO - 10.1097/01.chi.0000215326.51175.eb

M3 - Article

C2 - 16721314

AN - SCOPUS:33744827954

VL - 45

SP - 642

EP - 657

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

SN - 0890-8567

IS - 6

ER -